Search

everythinglearnresearchcommunity

for

Search:↓

IL-17 is more important than IFN-γ in causing severe hair loss in chronic alopecia areata.

CD8+ T cells re-expressing CD45RA may predict treatment resistance in severe alopecia areata.

Abnormal T-cells from thymomas cause non-motor symptoms in some myasthenia gravis patients.

IL-27 may help prevent hair loss by creating immune-suppressing cells.

CD4 T cells can cause alopecia areata by activating CD8 T cells to attack hair follicles.

Understanding how Regulatory T Cells work could help create treatments for certain skin diseases and cancers.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

IFN-γ production by CD4 T cells is crucial for causing alopecia areata.

Discoid lupus erythematosus involves immune activation and fibrosis around hair follicles, with shared pathways across humans, dogs, and mice, suggesting potential treatments for both humans and animals.

CD4 T cells need IFN-γ to cause hair loss in alopecia areata.

γδTregs may help treat autoimmune diseases like alopecia areata by promoting hair regrowth and reducing immune attacks.

Dandruff is linked to increased T cells and weakened immune protection in hair follicles.

Increasing regulatory T cells may help treat alopecia areata by reducing autoimmunity and promoting hair growth.

People with acne have more CD4+ immune cells in their skin than healthy people.

People with alopecia areata have fewer regulatory T-cells than those with other skin conditions.

Enhancing regulatory T cells may help treat autoimmune diseases like alopecia areata.

IL-17 and certain immune cells are linked to more severe alopecia areata.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

T-cell patterns in skin help distinguish alopecia areata from androgenetic alopecia.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

Minoxidil is more effective than Latanoprost for treating patchy alopecia areata.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

CD8+ T cells drive alopecia areata, while regulatory T cells are protective.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

Autoimmune hair loss may be linked to increased Th1 and Th17 cells and decreased Th2 cells.